NCT06999551View on ClinicalTrials.gov

Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Diabetes Mellitus
Interventions
DRUG

switch NPH to glargin

Switch of patients with type 2 diabetes mellitus from NPH insulin to insulin glargine

Trial Locations (1)

3000

Hedi Chaker Hospital, Sfax

All Listed Sponsors
lead

Les Laboratoires des Médicaments Stériles

INDUSTRY